Goldman Sachs Group »

Marinus Pharmaceuticals shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Marinus Pharmaceuticals (MRNS) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Marinus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Marinus Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Marinus Pharmaceuticals by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $789k 73k 10.87
2023-09-30 $935k 116k 8.05
2023-06-30 $712k 66k 10.86
2023-03-31 $1.1M 154k 6.90
2022-12-31 $669k 168k 3.98
2022-06-30 $220k 46k 4.83
2022-03-31 $1.5M 157k 9.35
2021-12-31 $1.8M 152k 11.88
2021-09-30 $2.7M 239k 11.38
2021-03-31 $3.6M 230k 15.48
2020-12-31 $768k 63k 12.20
2020-09-30 $408k 32k 12.86